These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9206054)

  • 1. [A randomized trial of tropisetron in the prophylaxis of nausea and vomiting induced by chemotherapy].
    Zhang P; Sun Y; Zhang H
    Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):154-6. PubMed ID: 9206054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical effect of Tropisetron in the prevention of nausea and vomiting induced by anti-cancer drugs].
    Wang J; Yang L; Cui C
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):251-3. PubMed ID: 11783100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive efficacies of china-made tropisetron hydrochloride and Navoban on chemotherapy-induced nausea and vomiting: a randomized controlled clinical trial].
    Xie M; Wu HY; Guo Y; Liu JL; Guan ZZ; Liu YL; Wang PH; Chen Q; Huang P; Yang JW
    Ai Zheng; 2005 Aug; 24(8):998-1001. PubMed ID: 16086881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Navoban (tropisetron) as effective as Zofran (ondansetron) in cisplatin-induced emesis? The French Navoban Study Group.
    Marty M; Kleisbauer JP; Fournel P; Vergnenegre A; Carles P; Loria-Kanza Y; Simonetta C; de Bruijn KM
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():15-21. PubMed ID: 7749165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
    Morrow GR; Hickok JT; Rosenthal SN
    Cancer; 1995 Aug; 76(3):343-57. PubMed ID: 8625113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy.
    Massidda B; Ionta MT
    J Chemother; 1996 Jun; 8(3):237-42. PubMed ID: 8808724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tropisetron hydrochloride in preventing and treating chemotherapy-induced nausea and vomiting: a phase II, randomized, multicenter, double-blinded, comparative clinical trial].
    Zhang WD; Wang XW; Chen ZD; Qin FZ; Shu YQ; Pan LX; Zhang MH
    Ai Zheng; 2007 Aug; 26(8):870-3. PubMed ID: 17697550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy.
    Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():9-14. PubMed ID: 7749170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.
    Van Belle SJ; Cocquyt VF; Bleiberg H; Canon JL; Buyse M; Hulstaert F; De Witte M; De Keyser P; Westelinck K
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():22-30. PubMed ID: 7749166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of tropisetron in the prevention of cisplatin-induced nausea and vomiting in advanced non-small cell lung cancer.
    Thongprasert S
    Acta Oncol; 2000; 39(2):221-4. PubMed ID: 10859015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of granisetron, ondansetron and tropisetron for control of vomiting and nausea induced by cisplatin.
    Oge A; Alkiş N; Oge O; Kartum A
    J Chemother; 2000 Feb; 12(1):105-8. PubMed ID: 10768522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropisetron alone or in combination with dexamethasone for the prevention and treatment of emesis induced by non-cisplatin chemotherapy: a randomized trial.
    Adams M; Soukop M; Barley V; Yosef H; Anderson H; Boesen E; Trask CW; Rüfenacht E; de Bruijn KM
    Anticancer Drugs; 1995 Aug; 6(4):514-21. PubMed ID: 7579555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin receptor antagonists in prophylaxis of acute and delayed emesis induced by moderately emetogenic, single-day chemotherapy: a randomized study.
    Yalçin S; Tekuzman G; Baltali E; Ozişik Y; Barişta I
    Am J Clin Oncol; 1999 Feb; 22(1):94-6. PubMed ID: 10025391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapy.
    Wymenga AN; van der Graaf WT; Wils JA; Siegenbeek van Heukelom L; van der Linden GH; Dullemond-Westland AC; Nooy M; van der Heul C; de Bruijn KM; de Vries EG
    Ann Oncol; 1996 Jul; 7(5):505-10. PubMed ID: 8839906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nausea disintegrating buccal tablet in the prevention of gastrointestinal reaction induced by anticancer drugs].
    Zhang P; Feng F; He Y; Li Y; Zhou M; Cheng G; Chen Y
    Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):504-7. PubMed ID: 12485511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.